Cesca Therapeutics Inc (NASDAQ:KOOL) shares saw an uptick in trading volume on Thursday . 1,053,059 shares traded hands during trading, an increase of 281% from the previous session’s volume of 276,462 shares.The stock last traded at $0.49 and had previously closed at $0.47.
Several research firms have recently issued reports on KOOL. ValuEngine upgraded Cesca Therapeutics from a “sell” rating to a “hold” rating in a report on Wednesday, May 2nd. HC Wainwright began coverage on Cesca Therapeutics in a report on Wednesday, May 23rd. They set a “buy” rating and a $1.50 price objective on the stock.
The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.79 and a current ratio of 1.61.
About Cesca Therapeutics
Cesca Therapeutics, Inc engages in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It operates through the Clinical Development Division and Device Division business segments. The Clinical Development Division segment involves in developing autologous stem cell-based therapeutics that address significant unmet medical needs for applications within the vascular, cardiology, and orthopedic markets.
Receive News & Ratings for Cesca Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cesca Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.